Streptolysin S is required for Streptococcus pyogenes nasopharyngeal and skin infection in HLA-transgenic mice
Blake A Shannon,Jacklyn R Hurst,Ronald S Flannagan,Heather C Craig,Aanchal Rishi,Katherine J Kasper,Stephen W Tuffs,David E Heinrichs,John K McCormick,Blake A. Shannon,Jacklyn R. Hurst,Ronald S. Flannagan,Heather C. Craig,Katherine J. Kasper,Stephen W. Tuffs,David E. Heinrichs,John K. McCormick
DOI: https://doi.org/10.1371/journal.ppat.1012072
IF: 7.464
2024-03-08
PLoS Pathogens
Abstract:Streptococcus pyogenes is a human-specific pathogen that commonly colonizes the upper respiratory tract and skin, causing a wide variety of diseases ranging from pharyngitis to necrotizing fasciitis and toxic shock syndrome. S . pyogenes has a repertoire of secreted virulence factors that promote infection and evasion of the host immune system including the cytolysins streptolysin O (SLO) and streptolysin S (SLS). S . pyogenes does not naturally infect the upper respiratory tract of mice although mice transgenic for MHC class II human leukocyte antigens (HLA) become highly susceptible. Here we used HLA-transgenic mice to assess the role of both SLO and SLS during both nasopharyngeal and skin infection. Using S . pyogenes MGAS8232 as a model strain, we found that an SLS-deficient strain exhibited a 100-fold reduction in bacterial recovery from the nasopharynx and a 10-fold reduction in bacterial burden in the skin, whereas an SLO-deficient strain did not exhibit any infection defects in these models. Furthermore, depletion of neutrophils significantly restored the bacterial burden of the SLS-deficient bacteria in skin, but not in the nasopharynx. In mice nasally infected with the wildtype S . pyogenes , there was a marked change in localization of the tight junction protein ZO-1 at the site of infection, demonstrating damage to the nasal epithelia that was absent in mice infected with the SLS-deficient strain. Overall, we conclude that SLS is required for the establishment of nasopharyngeal infection and skin infection in HLA-transgenic mice by S . pyogenes MGAS8232 and provide evidence that SLS contributes to nasopharyngeal infection through the localized destruction of nasal epithelia. Streptococcus pyogenes is a human-specific bacteria that causes a massive global burden of disease, ranging from mild infections such as strep throat, to more serious diseases such as flesh-eating disease and toxic shock syndrome. S . pyogenes has two toxins, streptolysin O (SLO) and streptolysin S (SLS), which contribute to disease progression by causing cell death. The streptolysins have been extensively studied in mouse models of skin and invasive infections; however, their role in nasal infection is understudied. We found that removal of the SLS toxin from the bacteria caused a significant reduction in the infection burden of nasal and skin tissues in mice. Interestingly, the SLO toxin was not a major contributor to disease in either of these infection models. We provide evidence suggesting that SLS targets the mucosal barrier in the nasal tissues of mice to help cause nasal infection. We also show that SLS helps cause skin infection by protecting the bacteria from neutrophils. Overall, strep throat and skin infections are the main S . pyogenes diseases, and this work has the potential to guide the development of therapies to prevent and treat S . pyogenes infections by targeting SLS.
microbiology,virology,parasitology